A Japanese biotech company is seeking an EU partner for collaborative research on drug discovery

Strong of its two platform technologies based on in silico drug screening technology for small molecules and a new modality for therapeutic peptide, the Japanese biotech company would like to enter into a collaborative research with EU pharmaceutical companies operating in drug research. The agreement could take the shape of a licensing one, financial one or research cooperation one.

View partnering opportunity